Brief: Lipigon Proposes To Delist Company From Nasdaq First NGM
15/04/2026 12:41
April 15 (Reuters) - Lipigon Pharmaceuticals AB LPGO.ST: PROPOSES TO DELIST COMPANY FROM NASDAQ FIRST NORTH GROWTH MARKET Source text: ID:nBQN1z2K7h Further company coverage: LPGO.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Lipigon Pharmaceuticals AB
See all newsBrief: Nasdaq To Delist Lipigon Pharmaceuticals From First North Growth Market
Brief: Lipigon Expected To Be Removed From Trading On Nasdaq Stockholm On May 18
Brief: Lipigon Proposes To Delist Company From Nasdaq First NGM
Brief: Lipigon Pharmaceuticals Oct-Dec Oper Loss At SEK 7.2 Mln
Brief: Lipigon Pharmaceuticals Aims To Reduce Cost Base By Two-Thirds